Stiff Competition: The generic drug industry competes with original branded drugs. When a branded drug loses exclusivity, generic competition intensifies as rivals undercut prices.

Although more than 20,000 medicines are on the market in Nepal, the country’s drug regulator has set a target of testing just 22 drugs in the next 12 months — and none of them are chemotherapy ...

Several smaller companies also develop generic versions of branded drugs, significantly cheaper than original drugs. Competition in this segment is stiff, resulting in thin margins for ...

The global Generic Drugs Market is valued at USD 487.21 Billion in 2024 and is projected to reach a value of USD 898 Billion ...

A patent gives the original drugmaker monopoly power for 20 years, or longer if the company finds a way to extend it. When a drug goes generic, many producers can make it, and the price plummets.

We could not find the seller of the generic CsA 0.05% sold by Cost Plus Drugs anywhere on its website, so I had a prescription sent to them.

The Drug Competition Enhancement Act targets "product hopping," a practice where companies switch patients to a slightly altered, newer version of a drug before the patent on the original drug ...

How could Trump's demands that drugmakers lower U.S. prices or face penalties impact pharma and biotech stocks? Seeking Alpha ...

Lower drug prices mean lower out-of-pocket expenses, fewer treatment delays and fewer financial trade-offs between health and household needs. For someone with cancer, that can be life-changing.